Skip to main content
  • Policy
    Get Involved
    Join BIOAction
    View Advocacy Toolkit
    Patient Advocacy
    Human Health
    Cost and Value of Biopharmaceuticals
    Antimicrobial Resistance
    Vaccines & Biodefense
    Drug Development & Review
    International
    Global Markets & Trade
    Multilateral Organizations
    Intellectual Property
    All Policy
    Patient Advocacy

    Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.

  • Member
    Membership Options
    Become a BIO Member
    Member Directory
    Have a Voice
    Membership Eligibility
    Member Toolkit
    Benefits By Sector
    member health
    Human Health
    member startups
    Startups
    member non R&D
    Non-R&D Companies
    Member Savings
    BBS-Programs-vwr
    VWR, Part of Avantor
    75% off Lab Supplies
    Save with BIO
    Save with BIO
  • News & Insights
    Latest biotech news
    Popular blogs
    Events
    Policy
    BIO Statements
    Press Releases
    Letters, Testimony & Comments
    Amicus Briefs
    BIO Reports
    Industry Analysis Reports
    Biotech Jobs
    Economic Development Best Practices
    BIO Briefly
    Issue Briefs
    BIO.News
    I am BIO Podcast
    All News & Insights

    Sign up for the BIO.News Newsletter >

  • Events
    Event Portfolio
    Business Development
    Health
    International
    Professional Development
    Members Only
    All Events
    BIO International Convention

    June 22-25, 2026 | San Diego, CA

    Learn More
    BIO Asia-Taiwan
    BIO Europe

    November 3-5, 2025
    Vienna, Austria

    BIO Investor Forum
    Partnering @JPM Week

    January 12-15, 2026
    San Francisco, CA

    BIO Patient & Health Advocacy Summit
    BIO Investment & Growth Summit

    March 2-3, 2026
    Miami, FL

    BIO Webinars

    Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.

  • About
    About Us
    Learn about our priorities
    BIO Leadership
    Meet BIO's Senior Leadership and Board of Directors
    Biotech Basics
    Read about biotechnology
    Industry Recognition
    Get to know the outstanding people and companies BIO supports
    Careers @ BIO
    Explore job openings with BIO today
    Diversity & Inclusion >

    Our tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.

  • Resource Hub
    Latest Resources
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Content Hub
    Biotech News (BIO.News)
    BIO.News Newsletter
    I am BIO Podcast
    BIO Advocacy Toolkit
    Resources Hub
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Webinars
    BIO Microsites
    Clinical Trials: The Power of Participation
    Covid Vaccine Facts
  • Search Results
    Previously Searched
Logo
Logo
Home
Search
  • Policy
    Human HealthPatient AdvocacyInternationalIntellectual PropertyAll Policies
  • Member
    Become a BIO MemberBenefits By Sector
    Human HealthStartupsNon-R&D Companies
    Member DirectoryHave a VoiceMembership EligibilitySavings
  • News & Insights
    Press ReleasesBio.News BlogLetters, Testimony & CommentsAmicus BriefsIndustry Analysis ReportsBiotech JobsEconomic Development Best PracticesIssue BriefsBIO.NewsVideosAll News & Insights
  • Events
    BIO International ConventionBIO Asia-TaiwanAll Events
  • About
    About UsBIO LeadershipDiversity & InclusionBiotech BasicsIndustry RecognitionCareers @ BIO
  • Resource Hub
    Biotech News (BIO.News)BIO.News NewsletterI am BIO PodcastBIO Advocacy ToolkitBIO Early-Stage Resources HubBIO Professional DevelopmentBIO WebinarsClinical Trials: The Power of ParticipationCovid Vaccine Facts
Search Results
Previously Searched
Search Results
Previously Searched
3123 results found
Expand All
Apply All
3123 results found

Good Day BIO: House moves on climate funding
Share
Good Day BIO Newsletter  •  July 2, 2021
Before you head out for the holiday weekend, we have an update on FY22 funding for USDA and FDA, as well as a recap of BIO’s Clinical Trial Diversity Summit with practical things we can do right now to improve trial diversity. (813 words, 4 minutes, 3 seconds) BIO is taking a break for the Fourth of July. Good Day BIO will resume regular publication on Monday, July 12. Enjoy your time with family and friends—and if you haven’t done so yet, it’s a great time to get your COVID vaccine!
Read More

BIO Job Application
Share
.field--type-webform span.form-required, .webform-submission-form span.form-required { display: block; font-size: 15px; font-family: "Poppins",sans-serif; font-weight: normal; width: 100%; } html legend { display: block; font-size: 15px; font-family: "Poppins",sans-serif; }
Read More

Good Day BIO: How you can help make our skies more sustainable
Share
Good Day BIO Newsletter  •  July 1, 2021
It’s a new month—and there’s a lot to do. The Sustainable Skies Act would help combat GHG emissions and temperature rise—but it needs your support. We’re also keeping the pressure on the administration about what we can do to address the global vaccine shortage and why an IP waiver won’t help. (905 words, 4 minutes, 31 seconds)
Read More

BIO Letter to USTR Ambassador Tai on Global Vaccine Distribution
Share
Human Health, Vaccines  •  Letters, Testimony & Comments  •  June 30, 2021
We would like to provide you some updates on the U.S. and global biotechnology industry’s efforts to scale-up global vaccine production to address the global imbalance in access to COVID vaccines, and to request a close working relationship with USTR now that the WTO has agreed to have text-based discussions on COVID and intellectual property (IP) rights.
Read More

Good Day BIO: USMCA at one year
Share
Good Day BIO Newsletter  •  June 30, 2021
It’s the one-year anniversary of the U.S.-Mexico-Canada Agreement (USMCA)—but we’re not celebrating yet. We explain why. On the other hand, a new report has us feeling optimistic about the resilience of the U.S. biotech industry and workforce. (859 words, 4 minutes, 17 seconds)
Read More

BIO Files Amicus Brief in Petition for a Writ of Certiorari in American Axle & Manufacturing, Inc., v. Neapco Holdings LLC, et al., at the Supreme Court of the United States.
Share
Intellectual Property, Patents  •  Amicus Brief  •  June 29, 2021
BIO and AUTM have filed an amicus brief in petition for a writ of certiorari the in American Axle & Manufacturing, Inc., v. Neapco Holdings LLC, et al., at the Supreme Court of the United States. BIO and AUTM are concerned that the Federal Circuit is misapplying the Supreme Court’s two-step test for subject matter eligibility and incorrectly mischaracterizing patent claims as directed to nothing more than a natural law. Under the reasoning set forth in lower court’s decision, any invention could be reduced to a natural law or abstract idea, and thus, held ineligible for patenting. BIO and AUTM are also concerned that the lower court’s decision improperly conflates subject matter eligibility with the enablement requirement found in 35 USC 112, further obscuring the law. Accordingly, BIO and AUTM ask the Court to clarify the law of patent eligibility to prevent further confusion and ensure consistency in its application.  
Read More

Good Day BIO: The vaccines work—if people get them
Share
Good Day BIO Newsletter  •  June 29, 2021
We got great news yesterday about the immune response generated by some of the COVID-19 vaccines—but there’s still work to do. Meanwhile, as heat and drought rage across the western U.S., we look at what it means for agriculture—and how gene editing can offer solutions. (613 words, 3 minutes, 3 seconds)
Read More

BIO: Where Breakthroughs Begin
Share

Good Day BIO: What the banana tells us about our food systems
Share
Good Day BIO Newsletter  •  June 28, 2021
Start your week with a nutritious, delicious banana—while you still can. Today’s episode of the I am BIO Podcast explores the threat to bananas and what it tells us about our food systems. We also have news on a BARDA decision that would affect R&D of COVID therapeutics as well as the bioeconomy bill moving through Congress. (797 words, 3 minutes, 59 seconds)
Read More

BIO letter to HHS Secretary Xavier Becerra on the importance of funding R&D for COVID-19 therapeutics at Biomedical Advanced Research and Development Agency (BARDA).
Share
Letters, Testimony & Comments  •  June 25, 2021
The partnership between the biopharmaceutical industry and the U.S. Government is largely responsible for where we are with the COVID-19 pandemic today. In just 16 months from the declaration of the pandemic, cases have dramatically dropped as more than 50% of U.S. adults have gotten vaccinated, and we now have proven treatments for cases of COVID-19. Despite this success, BIO and our members are concerned by the May 2021 change to the Biomedical Advanced Research and Development Agency (BARDA) Broad Agency Announcement (BAA) that suspends prioritization of Area of Interest (AOI) 9.2 -COVID-19 Therapeutics.
Read More

Pagination

  • First First page
  • Prev Previous page
  • …
  • 176
  • 177
  • 178
  • …
  • Next Next page
  • Last Last page
Biotechnology Innovation Organization
Explore BIO
Policy
Events
About
Industry Insights
Join Now
BIO PAC
For Members
Member Directory
BIO Policy Committees
Cost-Savings Program
BIO Events
BIO International Convention
BIO Partnering at JPM Week
BIO CEO & Investor Conference
BIO Investor Forum
BIO Patient Health & Advocacy Summit
BIO Intellectual Property Counsels Committee Conference
1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2025 All Rights Reserved
Privacy Policy
Terms of Use
Contact BIO